Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory illness, particularly in infants, the elderly, and immunocompromised adults. There is no licensed commercial vaccine against RSV. Importantly, formalin-inactivated RSV vaccines mediate enhanced respiratory disease. RSV fusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu, Bian, Lijun, Zhao, Huiting, Liu, Yulan, Lu, Jingcai, Liu, Dawei, Zhang, Ke, Song, Yueshuang, Luo, Yusi, Jiang, Chunlai, Chen, Yan, Zhang, Yong, Kong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516270/
https://www.ncbi.nlm.nih.gov/pubmed/33013922
http://dx.doi.org/10.3389/fimmu.2020.526965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516270/
https://www.ncbi.nlm.nih.gov/pubmed/33013922
http://dx.doi.org/10.3389/fimmu.2020.526965

Ejemplares similares